Publicacións (80) Publicacións de MARÍA DEL ROCÍO GARCÍA-RAMOS GARCÍA

2024

  1. Cognitive dysfunction characteristics of multiple sclerosis with aging

    Multiple Sclerosis and Related Disorders, Vol. 87

  2. Effectiveness and safety of levodopa–entacapone–carbidopa infusion in Parkinson disease: A real-world data study

    European Journal of Neurology

  3. Four-tract probabilistic tractography technique for target selection in essential tremor treatment with magnetic resonance–guided focused ultrasound

    European Radiology, Vol. 34, Núm. 8, pp. 5167-5178

  4. Palliative care in Parkinson's disease and other movement disorders. Recommendations and protocol of a multidisciplinary group of experts

    Neurologia

  5. Palliative care management in patients with Parkinson's disease and other movement disorders. National survey to neurologists

    Neurologia, Vol. 39, Núm. 5, pp. 417-425

  6. Prevalence of Myofascial Trigger Points in Isolated Idiopathic Cervical Dystonia: A Possible Contributor to Pain, Movement and Disability

    Movement Disorders Clinical Practice, Vol. 11, Núm. 9, pp. 1125-1131

  7. Sensitization-Associated Symptoms and Neuropathic-like Features in Patients with Cervical Dystonia and Pain

    Journal of Clinical Medicine, Vol. 13, Núm. 7

2023

  1. Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™

    Neurologia, Vol. 38, Núm. 5, pp. 326-333

  2. Levodopa–carbidopa intestinal gel in advanced Parkinson’s disease: long-term results from COSMOS

    Journal of Neurology, Vol. 270, Núm. 5, pp. 2765-2775

  3. Multi-Disease Validation of the RUDAS for Cognitive Screening in Alzheimer's Disease, Parkinson's Disease, and Multiple Sclerosis

    Journal of Alzheimer's disease : JAD, Vol. 91, Núm. 2, pp. 705-717

  4. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life

    Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402

  5. Validation of the European Cross-Cultural Neuropsychological Test Battery (CNTB) for the assessment of mild cognitive impairment due to Alzheimer's disease and Parkinson's disease

    Frontiers in Aging Neuroscience, Vol. 15

  6. Validation of the cross-cultural dementia screening test in Alzheimer’s disease and Parkinson’s disease

    Frontiers in Psychology, Vol. 13

2022

  1. Autosomal recessive spinocerebellar ataxia SCAR8/ARCA1: First families detected in Spain

    Neurologia, Vol. 37, Núm. 4, pp. 257-262

  2. Validation of the Spanish-language version of the Montreal Cognitive Assessment as a screening test for cognitive impairment in multiple sclerosis

    Neurologia, Vol. 37, Núm. 9, pp. 726-734

2021

  1. Depression in Alzheimer's Disease: A Delphi Consensus on Etiology, Risk Factors, and Clinical Management

    Frontiers in Psychiatry, Vol. 12

  2. Focus on Depression in Parkinson's Disease: A Delphi Consensus of Experts in Psychiatry, Neurology, and Geriatrics

    Parkinson's Disease, Vol. 2021

  3. Management of Parkinson's disease and other movement disorders in woman of childbearing age: Part 1

    Neurologia, Vol. 36, Núm. 2, pp. 149-158

  4. Management of Parkinson's disease and other movement disorders in women of childbearing age: Part 2

    Neurologia, Vol. 36, Núm. 2, pp. 159-168

  5. Manual básico de la SEN sobre el Final de la Vida y la Ley de la Eutanasia

    Editorial SEN